Advanced search
Publication Cover
Cancer Investigation Volume 7, 1989 - Issue 6
Submit an article Journal homepage
4
Views
5
CrossRef citations to date
0
Altmetric
Original Article

Intraperitoneal Cisplatin with Intravenous Cyclophosphamide and Doxorubicin for Previously Untreated Stage III and IV Ovarian Carcinoma

James A. Young Natalie Warren Bryant Cancer Center Tulsa, Oklahoma
,
Forrest Garretson Natalie Warren Bryant Cancer Center Tulsa, Oklahoma
,
Debra L. Westlake Natalie Warren Bryant Cancer Center Tulsa, Oklahoma
,
William P. Illig Natalie Warren Bryant Cancer Center Tulsa, Oklahoma
&
Steven E. Vogl Albert Einstein College of Medicine Bronx, New York
Pages 565-570 | Published online: 11 Jun 2009

References

  • Richardson G S, Scully R E, Nikrui N, et al. Common epithelial cancer of the ovary. N Engl J Med 1985; 312: 415–424; 474–483
  • Louie K G, Ozols R F, Myer C E, et al. Long-term results of a cisplatin-containing combination chemotherapy regimen for the treatment of advanced ovarian carcinoma. J Clin Oncol 1986; 4: 1579–1585
  • Dedrick R L, Myers C E, Bungay P M, et al. Pharmacokinetic rationale for peritoneal drug administration in the treatment of ovarian cancer. Cancer Treat Rep 1978; 62: 1–11
  • Howell S B, Pfeifle C E, Wang W E, et al. Intraperitoneal cisplatin with systemic thiosulfate protection. Ann Intern Med 1982; 97: 845–851
  • Pretorius R G, Hacker N F, Berek J S, et al. Pharmacokinetics of ip cisplatin in refractory ovarian carcinoma. Cancer Treat Rep 1983; 67: 1085–1092
  • Kaplan R A, Markman M, Lucas W E, et al. Infectious peritonitis in patients receiving intraperitoneal chemotherapy. Am J Med 1985; 78: 49–53
  • Pfeifle C E, Howell S B, Markman M, et al. Totally implantable system for peritoneal access. J Clin Oncol 1984; 2: 1277–1280
  • Young J A, Segler S. Outpatient cisplatin chemotherapy in a community hospital cancer center. J Okla St Med Soc 1985; 80: 343–346
  • Markman M, Cleary S, Lucas W E, et al. Intraperitoneal chemotherapy with high-dose cisplatin and cytosine arabinoside for refractory ovarian carcinoma and other malignancies principally involving the peritoneal cavity. J Clin Oncol 1985; 3: 925–931
  • McVie J G, ten Bokkel Huinink W W, Aartsen E, et al. Intraperitoneal chemotherapy in minimal residual ovarian cancer with cisplatin and sodium thiosulfate protection (abstr). Proc Am Soc Clin Oncol 1985; 4: 125
  • Ozols R F, Ostchega Y, Myers C E, et al. Cisplatin in hypertonic saline in refractory ovarian cancer. J Clin Oncol 1985; 3: 1246–1250
  • Levin L, Hryniuk W. Dose intensity analysis of chemotherapy regimens in ovarian carcinoma. J Clin Oncol 1987; 5: 756–767
  • Vogl S E, Farragi D, Kaplan B H. Dose-response relations for cisplatinum chemotherapy in metastatic ovarian cancer (abstr). Proc Am Soc Clin Oncol 1985; 4: 123

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.